PUBLICATION

Administration of recombinant IFN1 protects zebrafish (Danio rerio) from ISKNV infection

Authors
Li, Z., Xu, X., Huang, L., Wu, J., Lu, Q., Xiang, Z., Liao, J., Weng, S., Yu, X., and He, J.
ID
ZDB-PUB-100511-3
Date
2010
Source
Fish & shellfish immunology   29(3): 399-406 (Journal)
Registered Authors
Keywords
Interferon, Zebrafish (Danio rerio), ISKNV, Gene expression, Administration time
MeSH Terms
  • Animals
  • DNA Virus Infections/mortality
  • DNA Virus Infections/prevention & control*
  • Fish Diseases/mortality
  • Fish Diseases/prevention & control*
  • Gene Expression Regulation/drug effects*
  • Gene Expression Regulation, Viral/drug effects
  • Immunity, Innate/drug effects*
  • Interferons/administration & dosage*
  • Interferons/pharmacology
  • Iridoviridae/physiology
  • Recombinant Proteins/administration & dosage*
  • Recombinant Proteins/pharmacology
  • Survival Analysis
  • Time Factors
  • Viral Proteins/metabolism
  • Virion/drug effects
  • Zebrafish
  • Zebrafish Proteins/immunology
PubMed
20438850 Full text @ Fish Shellfish Immunol.
Abstract
In the present study, we used the infectious spleen and kidney necrosis virus (ISKNV) and zebrafish model system to investigate the inhibitory effect of recombinant zebrafish interferon 1 (zfrIFN1) on acute viral infection and the impact of time of zfrIFN1 administration on its protective efficacy. In vivo experiments showed that administration of recombinant zfrINF1 up-regulated expression of several IFN-stimulated genes within 24 h of injection, and expression levels of these genes dropped to normal levels similar to those in control fish within three days. However, the transcriptions of two viral genes, the major capsid protein and virus protein 48 genes, were significantly inhibited for at least three days, indicating a longer duration of the zfrIFN1-mediated innate immune effect. To evaluate the protective efficacy of zfrIFN1 against ISKNV infection, we compared the relative percentage survival (RPS) of ISKNV-infected zebrafish by intraperitoneally (IP) injecting the fish with zfrIFN1 at different time points before or after infection. IP injection with 1 mug zfrIFN1/g fish body weight at 24, 6 or 0 h before virus infection or 6 h after virus infection significantly improved fish survival. However, IP injection with an equal dose of zfrIFN1 24 h post-infection did not provide significant protection to the fish. Our results suggest that zfrIFN1 is potent in inhibiting ISKNV acute infection and initiating the innate immune response in zebrafish, but its efficiency depends on the time of administration. This study shows the protective effects of interferon against a DNA-virus in fish for the first time and provides information about the efficacy of fish interferon that will prove useful in possible therapeutic applications.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping